MINNEAPOLIS, July 13, 2026 (GLOBE NEWSWIRE) — Tactile Systems Tech ology, I c. (“Tactile Medical”; the “Compa y”) (Nasdaq: TCMD), a medical tech ology compa y p ovidi g the apies fo people with ch o ic diso de s, today a ou ced it has e te ed i to a exclusive dist ibutio ag eeme t with ElastiMed, I c. to b i g MyoSleeve™, its disc eet, wea able o -p eumatic comp essio device fo the lowe leg, to Depa tme t of Vete a s Affai s (VA) a d Depa tme t of Defe se (DoD) patie ts ac oss the U ited States. MyoSleeve expa ds Tactile Medical’s established ma ket-leadi g po tfolio by p ovidi g a ew t eatme t optio fo app op iately selected patie ts i ea lie stages of ch o ic swelli g who may ot yet equi e mo e i te sive comp essio the apy. MyoSleeve may also be app op iate as a compleme ta y t eatme t to a t aditio al p eumatic comp essio device a d fo patie ts who st uggle with co se vative the apy, o those with mobility-limiti g cases.
W apped a ou d the calf with the ability to be wo be eath clothi g, MyoSleeve uses elect oactive polyme tech ology to delive dy amic comp essio th ough flexible ba ds that co t act i seque ce. The batte y-powe ed device is desig ed as a all-i -o e the apy optio , ope ati g without tubi g, co ds, o a exte al co t olle , a d quietly delive s i te mitte t the apy while patie ts go about daily activities. MyoSleeve has eceived U.S. Food a d D ug Admi ist atio 510(k) clea a ce a d is i dicated fo the t eatme t of ch o ic swelli g, i cludi g ch o ic edema, lymphedema, a d ve ous i sufficie cy.
U de the ag eeme t, Tactile Medical holds exclusive U.S. dist ibutio ights fo MyoSleeve withi the VA a d DoD systems. I co ectio with these exclusive dist ibutio ights, the Compa y made a upf o t payme t of $3 millio to ElastiMed. The Compa y also committed to ce tai mi imum pu chase obligatio s a d ma keti g a d sales p omotio as it suppo ts ElastiMed’s g owth. The Compa y expects to leve age its established sales o ga izatio , billi g a d payme t expe tise, a d patie t suppo t i f ast uctu e to d ive MyoSleeve comme cializatio a d suppo t o goi g ma ket access i itiatives. MyoSleeve is available by p esc iptio , a d app op iate patie t selectio is dete mi ed by the t eati g cli icia .
“Ou ag eeme t with ElastiMed adds a diffe e tiated, wea able comp essio optio to Tactile Medical’s po tfolio a d eflects ou st ategy of expa di g access to patie t-focused solutio s ac oss the co ti uum of ch o ic swelli g ca e,” said She i Dodd, Chief Executive Office of Tactile Medical. “Fo the ight patie t, MyoSleeve offe s u obt usive comp essio the apy that fits i to daily life, givi g patie ts the f eedom to stay mobile while e gaged i thei ow ca e.”
“Pa t e i g with Tactile Medical gives MyoSleeve a di ect path to ce tai patie ts with ch o ic swelli g who wa t to stay active while getti g the t eatme t they eed,” said Ome Zelka, Chief Executive Office of ElastiMed. “It is the fi st ambulato y all-i -o e, cable-f ee, cli ical-g ade solutio fo patie ts with ve ous a d lymphatic co ditio s. This pa t e ship e ables the fi st comme cial i t oductio of MyoSleeve th ough a t usted a d ma ket-leadi g medical device pa t e .”
“Comp essio the apy is ot o e-size-fits-all. Cli icia s achieve the best outcomes whe they have a a ge of optio s that ca be matched to disease seve ity, a atomy, a d lifestyle,” said To y Gaspa is, MD, Chief Medical Office of Tactile Medical. “MyoSleeve i t oduces a impo ta t ew optio fo app op iately selected patie ts with lowe -leg swelli g, offe i g active comp essio that is well-suited fo ea lie stages of disease, whe e co siste t the apy adhe e ce is key to slowi g disease p og essio . Impo ta tly, MyoSleeve is desig ed to compleme t — ot eplace — adva ced p eumatic comp essio the apies, which emai the sta da d of ca e fo patie ts with mo e exte sive o adva ced disease.”
Fo mo e i fo matio about MyoSleeve, please visit https://tactilemedical.com/myosleeve/.
Tactile Medical is a leade i developi g a d ma keti g at-home the apies fo people suffe i g f om u de se ved, ch o ic co ditio s i cludi g lymphedema, lipedema, ch o ic ve ous i sufficie cy a d ch o ic i flammato y lu g disease by helpi g them live bette a d ca e fo themselves. Tactile Medical collabo ates with cli icia s to expa d cli ical evide ce, aise awa e ess, i c ease access to ca e, educe ove all healthca e costs a d imp ove the quality of life fo te s of thousa ds of patie ts each yea .
ElastiMed is a comme cial-stage medical device compa y developi g wea able the apeutic devices based o elect oactive polyme (EAP) tech ology, desig ed to delive dy amic comp essio i a comfo table, low-p ofile, a d easy-to-use fo m.
